Life Sciences Tools and Services
Company Overview of EMD Millipore Corporation
EMD Millipore Corporation provides tools, technologies, and application solutions for research, development, and production of biotech and pharmaceutical drug therapies. It offers products for diagnostics/OEM, up and downstream bioprocessing, drug discovery and development, laboratory filtration and water, life science research, and process monitoring applications, as well as specialty markets. The company also provides life science services that include antibodies, custom media, and flow cytometry services; drug discovery and development services, such as immunoassay/biomarker, preclinical/clinical development, target screening and profiling, and flex laboratory services; and bioprocess ser...
290 Concord Road
Billerica, MA 01821-7037
Founded in 1954
Key Executives for EMD Millipore Corporation
Head of Global Operations and Member of Management Board
Member of Management Board and President of Emd Millipore Division
Member of Management Board and Head of Emd Millipore's Process Solutions Business Unit
Member of Management Board and Head of Emd Millipore's Bioscience Business Unit
Compensation as of Fiscal Year 2013.
EMD Millipore Corporation Key Developments
Millipore Corporation Presents at 2013 BIO Convention in China, Nov-13-2013 09:30 AM
Nov 11 13
Millipore Corporation Presents at 2013 BIO Convention in China, Nov-13-2013 09:30 AM. Venue: China National Convention Center, No.7 Tianchen East Road, Chaoyang District, Beijing 100105, China.
Firefly BioWorks Enters into a Strategic Partnership with EMD Millipore
Oct 16 13
Firefly BioWorks announced that it has entered into a strategic partnership with EMD Millipore. Under the terms of the agreement, EMD Millipore will lead global distribution of the Firefly(TM) microRNA Assay, the first product to be developed on the Firefly(TM) Discovery Platform. Marketed by EMD Millipore under the name SmartRNAPlex(TM), the assay enables rapid profiling of up to 68 microRNA targets per sample in a 96-well plate format using standard flow cytometers. SmartRNAPlex(TM) is a powerful new addition to Millipore's growing portfolio of RNA profiling products. Until now, analyzing large numbers of samples across multiple microRNAs required splitting the samples into parallel qPCR reactions or using low-throughput technologies such as microarrays. SmartRNAPlex(TM) overcomes this limitation, affording the user both multiplexing and high-throughput capabilities. SmartRNAPlex(TM) is designed for the large installed base of standard flow cytometers, which significantly decreases adoption costs. This new tool promises to accelerate the pace of microRNA biomarker validation and catalyze the translation of basic biological understanding into clinical diagnostics and drug discovery applications.
Luminex Corporation and Millipore Corporation Extend Their Global Supply and Distribution Agreement
May 28 13
Luminex Corporation announced that it has extended their global supply and distribution agreement with Millipore Corporation, the Life Science division of Merck KGaA. This long-term agreement strengthens the partnership and facilitates development of life science and protein assays by EMD Millipore for Luminex's flexible platform. As part of the agreement, EMD Millipore will continue to offer the full range of Luminex's xMAP(R) systems, including MAGPIX(R), Luminex(R) 100/200(TM), and FLEXMAP 3D(R). Luminex Technology is widely supported and validated across both clinical and life science research markets, with cumulative shipments to date nearing 10,000 total instruments and over 16,000 publications across a broad spectrum of applications.
Similar Private Companies By Industry
Recent Private Companies Transactions